Latest Breaking News On - David koelle - Page 1 : comparemela.com

Study predicts good passive immunotherapy donors to combat COVID-19 The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Since the virus first emerged in late-2019, over 95.55 million cases and more than 2 million deaths have been reported. Many countries have commenced targeted vaccination efforts to control the spread of the virus and immunize vulnerable groups. However, vaccine rollout may still lag behind ongoing infections, as fast-spreading new variants threaten many countries. Finding an effective therapy to help patients fight the infection remains crucial. Passive immunotherapy treatment, wherein SARS-CoV-2-neutralizing antibodies (nAbs) from the plasma of recovered patients are administered to acutely sick patients, is a promising method for COVID-19 treatment in severe cases.

United statesDavid koelleAngela betsaidab laguipoUniversity of washingtonNational institute of healthKoelle laboratoryDrug administrationFred hutchinson cancer research centerAngela betsaidaNational instituteClinical investigationCoronavirus disease covid 19Sars cov 2Convalescent plasmaCorona virusImmune system